Axon to Offer $1.0 Billion 0% Convertible Senior Notes Due 2031 and Expands Credit Facility
AXON sits 40% above its 52-week low of $339.01.
Summary
Axon announced a $1.0 billion offering of 0% convertible senior notes due 2031 and expanded its revolving credit facility to $500 million, significantly boosting its financial flexibility for growth and operations.
Key Events · Financing and Capital Events · AXON
-
$1.0 Billion 0% Convertible Senior Notes Offering
Axon is offering $1.0 billion in 0% Convertible Senior Notes due September 15, 2031, with an additional $150 million over-allotment option for underwriters. The notes will not bear regular interest.
-
Capped Call Transactions to Mitigate Dilution
The company expects to enter into privately negotiated capped call transactions to generally reduce potential dilution to common stock upon conversion of the notes and/or offset potential cash payments.
-
Expanded Revolving Credit Facility
Axon amended its credit agreement, increasing its revolving credit facility from $300 million to $500 million, with the ability to further increase by $150 million, and extending its maturity to up to five years.
-
Use of Proceeds for Growth and General Purposes
Net proceeds from the offering will be used to pay for the capped call transactions, with the remainder allocated to general corporate purposes, including supporting growth and potential acquisitions or investments.
Analysis · AXON · Manufacturing
Axon is launching a substantial $1.0 billion offering of 0% convertible senior notes, a highly favorable financing move that provides significant capital at no regular interest cost. This, coupled with the expansion of its revolving credit facility from $300 million to $500 million and an extended maturity, substantially boosts the company's financial flexibility and liquidity. The capital will support general corporate purposes, including growth initiatives and potential acquisitions. While convertible notes introduce potential future dilution, Axon plans to enter into capped call transactions to mitigate this risk. This proactive capital raise, following strong Q2 results, positions Axon for continued strategic investments and operational agility.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 35.7% of the 1179 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.44%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AXON was trading at $475.29 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $39.8B. The 52-week trading range was $339.01 to $792.16. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.